Press release
Generic Drugs Market Size Worth US$ 628.0 Billion during 2024-2032, With a CAGR of 5.96% | IMARC Group
The global generic drugs market size reached US$ 367.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.0 Billion by 2032, exhibiting a growth rate (CAGR) of 5.96% during 2024-2032.
Get Sample Copy of Report at - https://www.imarcgroup.com/generic-drug-manufacturing-plant/requestsample
Factors Affecting the Growth of the Generic Drugs Industry:
• Patent Expirations of Branded Drugs:
The expiration of patents for branded drugs is a critical driver for the generic drugs market. When patents expire, it opens the door for manufacturers to produce generic versions of these drugs, which are significantly more affordable than their branded counterparts.
This not only broadens the availability of essential medications to a wider population but also introduces competition in the market, leading to lower drug prices overall. The transition from branded to generic drugs following patent expiry is crucial in making healthcare more accessible and affordable, especially in low- and middle-income countries where the cost of medication can be a major barrier to accessing healthcare.
• Healthcare Cost Containment:
With healthcare costs escalating globally, there is an increasing emphasis on cost containment, making generic drugs an attractive option. Generic drugs provide a cost-effective alternative without compromising on efficacy, allowing healthcare systems to allocate resources more efficiently.
This is particularly important in countries with public health systems or where insurance coverage is limited. By reducing the financial burden of medication, generic drugs play a vital role in maintaining the sustainability of healthcare systems and ensuring broader access to essential treatments.
• Increasing Prevalence of Chronic Diseases:
The global rise in chronic diseases like diabetes, cardiovascular disorders, and various forms of cancer has led to a growing need for long-term and affordable medication among the masses. Generic drugs are pivotal in meeting this demand, as they offer the same therapeutic benefits as branded drugs but at a fraction of the cost. This affordability is essential for patients who require long-term or ongoing treatment, making generic drugs a key component in managing the global health burden of chronic diseases.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/generic-drug-manufacturing-plant
Global Generic Drugs Market Trends:
The global market is experiencing significant growth, driven by a confluence of factors. Foremost among these is the evolving regulatory landscape, which increasingly favors the production and approval of generic drugs. This regulatory support is crucial in reducing the time and cost associated with bringing generic medications to market, thereby enhancing their availability and affordability.
Another critical factor is the aging global population, particularly more prone to chronic health conditions such as heart disease, diabetes, and arthritis. As life expectancy increases, so does the prevalence of these long-term health issues, leading to a sustained demand for affordable medication. Generic drugs, being cost-effective, are ideally suited to meet this growing need, providing older adults with access to essential treatments without the financial burden often associated with branded medications.
Top Generic Drugs Companies Worldwide :
• Teva Pharmaceuticals Industries Ltd.
• Mylan N.V.
• Novartis AG
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• Fresenius SE & Co.
• Lupin Limited
• Endo Pharmaceuticals Inc.
• Aurobindo Pharma Limited
• Aspen Pharmacare Holdings Limited
Generic Drugs Market Report Segmentation:
By Therapy Area:
• Central Nervous System
• Cardiovascular
• Dermatology
• Genitourinary/Hormonal
• Respiratory
• Rheumatology
• Diabetes
• Oncology
• Others
Central nervous system dominates the market due to its high prevalence of neurological disorders and ongoing research in this area.
By Drug Delivery:
• Oral
• Injectables
• Dermal/Topical
• Inhalers
Oral holds the largest share in the market due to its ease of administration and patient compliance.
By Distribution Channel:
• Retail Pharmacies
• Hospital Pharmacies
Retail pharmacies account for the majority of the market share as they are the most accessible point of purchase for most consumers.
Country Insights:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
The United States' dominance in the generic drugs market is attributed to the high demand for cost-effective medications and supportive regulatory policies.
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Browse More Reports:
• https://industrytoday.co.uk/chemicals/ceiling-tiles-market-size-worth-us-99-billion-during-2024-2032-with-a-cagr-of-36-imarc-group
• https://industrytoday.co.uk/chemicals/battery-recycling-market-size-worth-us-299-billion-during-2024-2032-with-a-cagr-of-72-imarc-group
• https://industrytoday.co.uk/agriculture/precision-agriculture-market-size-worth-us-202-billion-during-2024-2032-with-a-cagr-of-99-imarc-group
• https://industrytoday.co.uk/it/blockchain-gaming-market-report-2024-size-us-8544-billion-trends-top-companies-growth-cagr-of-652-forecast-2032
• https://industrytoday.co.uk/market-research-industry-today/family-offices-market-report-2024-size-us-2926-billion-share-latest-trends-outlook-forecast-report-2032
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
Who we are:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Generic Drugs Market Size Worth US$ 628.0 Billion during 2024-2032, With a CAGR of 5.96% | IMARC Group here
News-ID: 3375467 • Views: …
More Releases from IMARC Group
Flexible Printed Circuits Manufacturing Plant Cost 2025: Industry Trends, Unit S …
Setting up a flexible printed circuits manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Flexible Printed Circuits Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a…
Needle Manufacturing Plant 2025: Project Report, Business Plan, Raw Materials, a …
Setting up a needle manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Needle Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a needle manufacturing plant, covering…
Edible Oil Manufacturing Plant Setup Cost 2025: CapEx/OpEx Analysis with Profita …
Setting up an edible oil manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Edible Oil Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing an edible oil…
Copper Alloys Manufacturing Plant Setup Cost 2025: Layout, Machinery, Raw Materi …
Setting up a copper alloys manufacturing facility necessitates a detailed market analysis alongside granular insights into various operational aspects, including unit processes, raw material procurement, utility provisions, infrastructure setup, machinery and technology specifications, workforce planning, logistics, and financial considerations.
IMARC Group's report titled "Copper Alloys Manufacturing Plant Project Report 2025: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" offers a comprehensive guide for establishing a copper alloys…
More Releases for Generic
Prominent Generic Oncology Drugs Market Trend for 2025: Novel Formulations Trans …
Which drivers are expected to have the greatest impact on the over the generic oncology drugs market's growth?
The upward trend in cancer incidence is predicted to fuel the expansion of the generic oncology drugs market. Cancer, characterized by unregulated cell proliferation affecting numerous organs, results in considerable morbidity and mortality globally. The provision of affordable generic oncology drugs is an instrumental factor in cancer care, expanding access to vital treatments,…
Generic Theater Presents Flyin' West
NORFOLK, VA (August 2023) - Generic Theater inaugurates its 43rd season with Flyin' West, written by award-winning playwright and New York Times bestselling author Pearl Cleage. Terrance Afer-Anderson directs this production, running weekends September 8th - October 1st at Generic Theater, Norfolk's underground theater located in the basement of Chrysler Hall.
Following the end of the Civil War, many former slaves took advantage of The Homestead Act and went West to…
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
Generic Drugs: Global Collaboration Opportunities
Collaboration is the key to growth
With the recent economic turmoil affecting many markets around the world, the generic and branded sectors face similar problems.
At one time the generic sector was seen as a valuable way to bring effective products to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of…
